Sofie Denies

602 total citations
15 papers, 293 citations indexed

About

Sofie Denies is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sofie Denies has authored 15 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Sofie Denies's work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Virus-based gene therapy research (4 papers). Sofie Denies is often cited by papers focused on CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers) and Virus-based gene therapy research (4 papers). Sofie Denies collaborates with scholars based in Belgium, United States and United Kingdom. Sofie Denies's co-authors include Niek N. Sanders, Yann G.‐J. Sterckx, Karine Breckpot, Yvon Elkrim, Tony Lahoutte, Catarina Xavier, Serge Muyldermans, Chloé Ackaert, Marleen Keyaerts and Nick Devoogdt and has published in prestigious journals such as Cancer Research, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Sofie Denies

14 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofie Denies Belgium 8 122 119 110 108 54 15 293
Zhewei Tang China 6 87 0.7× 128 1.1× 64 0.6× 93 0.9× 17 0.3× 8 305
Mary John United Arab Emirates 5 205 1.7× 152 1.3× 134 1.2× 91 0.8× 53 1.0× 10 359
Zea Melton United States 7 120 1.0× 113 0.9× 66 0.6× 165 1.5× 28 0.5× 8 288
Meike Hutt Germany 10 91 0.7× 219 1.8× 171 1.6× 112 1.0× 26 0.5× 16 338
Brian T. Rekoske United States 8 205 1.7× 118 1.0× 138 1.3× 292 2.7× 35 0.6× 10 471
Hayat Bähr-Mahmud Germany 6 104 0.9× 186 1.6× 52 0.5× 107 1.0× 75 1.4× 6 312
John Zielinski United States 4 236 1.9× 177 1.5× 37 0.3× 134 1.2× 64 1.2× 5 360
Dries Renmans Belgium 8 296 2.4× 253 2.1× 70 0.6× 244 2.3× 60 1.1× 9 500
Jo Soden United States 9 88 0.7× 117 1.0× 64 0.6× 111 1.0× 26 0.5× 10 263
Stefania Carrara Germany 10 62 0.5× 126 1.1× 108 1.0× 91 0.8× 27 0.5× 30 317

Countries citing papers authored by Sofie Denies

Since Specialization
Citations

This map shows the geographic impact of Sofie Denies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Denies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Denies more than expected).

Fields of papers citing papers by Sofie Denies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Denies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Denies. The network helps show where Sofie Denies may publish in the future.

Co-authorship network of co-authors of Sofie Denies

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Denies. A scholar is included among the top collaborators of Sofie Denies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Denies. Sofie Denies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mora, Johanna, Jennifer Hu, Jochem Gokemeijer, et al.. (2024). Immunogenicity Risk Assessment of Process-Related Impurities in An Engineered T Cell Receptor Cellular Product. Journal of Pharmaceutical Sciences. 113(8). 2151–2160. 1 indexed citations
2.
Tourdot, Sophie, Sofie Denies, Viswanath Devanarayan, et al.. (2024). Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals. mAbs. 16(1). 2324801–2324801.
3.
Ackaert, Chloé, Catarina Xavier, Yann G.‐J. Sterckx, et al.. (2021). Immunogenicity Risk Profile of Nanobodies. Frontiers in Immunology. 12. 632687–632687. 143 indexed citations
4.
5.
Leroy, Xavier, Sofie Denies, Virginie Rabolli, et al.. (2018). Abstract LB-114: a-TIGIT antagonist antibody EOS884448 shows dual mechanism of action by restoration of T cell effector functions and preferential depletion of Treg. Cancer Research. 78(13_Supplement). LB–114. 4 indexed citations
6.
Denies, Sofie, Bregje Leyman, Francis Combes, et al.. (2017). Evaluation of a xenogeneic vascular endothelial growth factor-2 vaccine in two preclinical metastatic tumor models in mice. Cancer Immunology Immunotherapy. 66(12). 1545–1555. 3 indexed citations
7.
8.
Denies, Sofie, et al.. (2016). In vitro exploration of a myeloid-derived suppressor cell line as vehicle for cancer gene therapy. Cancer Gene Therapy. 24(4). 149–155. 6 indexed citations
9.
Denies, Sofie, Hendrik Haers, Katrien Vanderperren, et al.. (2016). Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer. Veterinary and Comparative Oncology. 15(4). 1187–1205. 29 indexed citations
10.
Denies, Sofie, et al.. (2016). Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs. Oncotarget. 7(10). 10905–10916. 17 indexed citations
11.
Steenbrugge, Jonas, Koen Breyne, Sofie Denies, et al.. (2016). Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 21(3-4). 113–122. 12 indexed citations
12.
Denies, Sofie, H. de Rooster, Sylvie Daminet, et al.. (2016). Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patients. Veterinary and Comparative Oncology. 15(2). 594–605. 11 indexed citations
13.
Denies, Sofie, et al.. (2015). Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?. OncoImmunology. 4(12). e1048413–e1048413. 5 indexed citations
14.
15.
Denies, Sofie & Niek N. Sanders. (2012). Recent progress in canine tumor vaccination: potential applications for human tumor vaccines. Expert Review of Vaccines. 11(11). 1375–1386. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhewei Tang Breakdown of academic impact, for papers by Mary John Breakdown of academic impact, for papers by Zea Melton Breakdown of academic impact, for papers by Meike Hutt Breakdown of academic impact, for papers by Brian T. Rekoske Breakdown of academic impact, for papers by Hayat Bähr-Mahmud Breakdown of academic impact, for papers by John Zielinski Breakdown of academic impact, for papers by Dries Renmans Breakdown of academic impact, for papers by Jo Soden Breakdown of academic impact, for papers by Stefania Carrara
Rankless by CCL
2026